Atlas Trials

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours

Clinical trial NCT03328065 · TERMINATED

Trial details

NCT number
NCT03328065
Sponsor
Centre Hospitalier Universitaire Dijon
Status
TERMINATED
Study type
OBSERVATIONAL
Non-resectable Metastatic Cancer of the LungNon-resectable Metastatic Cancer of the ColonNon-resectable Metastatic Cancer of the Rectosigmoid JunctionNon-resectable Metastatic Cancer of the StomachNon-resectable Metastatic Cancer of the Bile DuctNon-resectable Metastatic Cancer of the RectumNon-resectable Metastatic Cancer of Gastrointestinal Neuroendocrine TumourNon-resecable Metastatic Cancer of the Pancreas
Start date
2017-12-19
Primary completion
2020-12-09
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.